Opdivo plus Yervoy also led to an overall response rate of 36.1 percent compared with 13.2 percent for patients treated with lenvatinib or sorafenib (complete response, 6.9 versus 1.8 percent ...

From breaking news to special features, we're on it! Join the NonStop Local Chord group and always be in the know. TUESDAY, April 15, 2025 (HealthDay News) -- The U.S. Food and Drug Administration ...